The largest database of trusted experimental protocols

Trichostatin a tsa

Manufactured by Merck Group
Sourced in United States, Germany, United Kingdom, Spain

Trichostatin A (TSA) is a laboratory reagent used in biological research. It is a histone deacetylase (HDAC) inhibitor, which means it can block the activity of HDAC enzymes. TSA is commonly used as a tool to study the role of histone acetylation in cellular processes.

Automatically generated - may contain errors

207 protocols using trichostatin a tsa

1

Epigenetic Modulation of hiPSCs

Check if the same lab product or an alternative is used in the 5 most similar protocols
The AlphoidtetO-HAC-GFP hiPSCs were cultured for 24 h in mTeSR-1 media in the presence of DNA methyltransferase inhibitor 5-Aza-2’-deoxycytidine (AZA) (Sigma-Aldrich, St. Louis, MO, USA) or histone deacetylase inhibitor trichostatin A (TSA) (Sigma-Aldrich, St. Louis, MO, USA) at concentrations of 5–10 μM and 0.5 μM, respectively. The AlphoidtetO-HAC-GFP hiPSCs were cultured for 72 h in the presence of 100–400 nM AZA or 19–38 nM TSA. The GFP-expression in the living cells was monitored by fluorescent and phase contrast light microscopy (EVOS FL Auto Imaging System, Thermo Fisher Scientific, Waltham, MA, USA).
The AlphoidtetO-HAC-GFP hiPSCs were cultured for 24 h in mTeSR-1 media in the presence of DNA methyltransferase inhibitor 5-Aza-2’-deoxycytidine (AZA) (Sigma-Aldrich, St. Louis, MO, USA) or histone deacetylase inhibitor trichostatin A (TSA) (Sigma-Aldrich, St. Louis, MO, USA) at concentrations of 5–10 μM and 0.5 μM, respectively. The AlphoidtetO-HAC-GFP hiPSCs were cultured for 72 h in the presence of 100–400 nM AZA or 19–38 nM TSA. The GFP-expression in the living cells was monitored by fluorescent and phase contrast light microscopy (EVOS FL Auto Imaging System, Thermo Fisher Scientific, Waltham, MA, USA).
+ Open protocol
+ Expand
2

Modulation of NK cell lines

Check if the same lab product or an alternative is used in the 5 most similar protocols
The cell lines DERL-2, DERL-7, KHYG-1, NK-92, YT, and LOUCY were obtained from the DSMZ (Braunschweig, Germany) and cultivated as described elsewhere [24 (link), 68 ]. The NK-cell line IMC-1 was kindly obtained from Dr. I. Ming Chen (Albuquerque, NM), NKL from Dr. Jerome Ritz (Boston, MA), and SNK-6 from Dr. N. Shimizu (Tokyo, Japan) [69 (link), 70 (link), 71 (link)]. To modify gene expression levels we used gene specific siRNA oligonucleotides in comparison to AllStars negative Control siRNA (siCTR) which were obtained from Qiagen (Hilden, Germany). SiRNAs (80 pmol) were transfected into 1x106 cells by electroporation using the EPI-2500 impulse generator (Fischer, Heidelberg, Germany) at 350 V for 10 ms. Electroporated cells were harvested after 20 h cultivation. Cells were variously treated for 16 h with 20 ng/ml recombinant BMP4, with 1 or 10 ng/ml recombinant PDGFD (R & D Systems, Abingdon, UK), with 100 μM Dasatinib (LC Laboratories, Woburn, MA), with 5 μM BMP receptor inhibitor dorsomorphin (DM) (Calbiochem, Darmstadt, Germany) dissolved in dimethyl sulfoxide (DMSO), with 10 μM EZH2-inhibitor DZNep (Sigma, Taufkirchen, Germany), or with 10 μg/ml histone deacetylase inhibitor trichostatin A (TSA) (Sigma).
+ Open protocol
+ Expand
3

Tuba and Trichostatin A Treatment Conditions

Check if the same lab product or an alternative is used in the 5 most similar protocols
TubastatinA (TubA, Chemie Tek) and Trichostatin A (TSA, Sigma) were dissolved in DMSO (1 mM and 20 μM, respectively) prior to further dilution in medium. All other chemicals were obtained from Sigma Aldrich, unless otherwise indicated. Cells were treated with 20 μM TubA for 3 h, unless otherwise indicated.
+ Open protocol
+ Expand
4

Histone Deacetylase Inhibitor Effects

Check if the same lab product or an alternative is used in the 5 most similar protocols
The HDAC inhibitors trichostatin A (TSA) and nicotinamide were obtained from Sigma (USA). Entamoeba histolytica trophozoites with a trigger-silenced ROM1 gene were grown for 24 h before treatment with the inhibitors. The inhibitors were used at the following concentrations: nicotinamide (2.5 mM, 5 mM, 10 mM or 20 mM) for 24 h and TSA (50 nM, 100 nM or 150 nM) for 48 h. After inhibitor treatment, cells were harvested, total RNA isolated (mirVana kit, Ambion) and cDNA synthesized (SuperScript II Reverse Transcriptase, Invitrogen). Cell growth was monitored at all the tested drug concentrations and confirmed the confluence and growth of the drug -treated cells.
+ Open protocol
+ Expand
5

Plasmid Transfection with Trichostatin A

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cells grown in 6-well plates were transfected with 1 μg plasmid DNA using either Lipofectamine 2000 (Invitrogen) or X-tremeGENE 9 (Roche) according to the manufacturer's instructions. The lipid–DNA complexes were replaced with media 4–6 hours posttransfection. To prevent histone deacetylation, Trichostatin A (TSA, Sigma) was added to the cells overnight. Cells were maintained in medium for a total of 48 hours prior to making whole-cell lysates.
+ Open protocol
+ Expand
6

Cell Culture and Reagent Preparation

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cell culture supplies, including Roswell Park Memorial Institute media (RPMI 1640) with L-glutamine, penicillin (100 units/ml)/streptomycin (100 μg/ml), fetal bovine serum (FBS), phosphate-buffered saline (PBS) 1× without calcium and magnesium, trypsin EDTA (0.05% trypsin, 0.53mM EDTA in Hank’s Balanced Salt Solution- without sodium bicarbonate, calcium, and magnesium) 1×, were purchased from Mediatech, Inc. (Herndon, VA). Valproic acid sodium salt (VPA), sodium butyrate (NaB) and Trichostatin A (TSA) were purchased from Sigma-Aldrich (St. Louis, MO). AlamarBlue reagent was purchased from Life Technologies (Grand Island, NY).
+ Open protocol
+ Expand
7

Epigenetic Regulation of Gastric Cancer

Check if the same lab product or an alternative is used in the 5 most similar protocols
Human gastric mucosal cells (GES-1) and gastric cancer cell lines (HGC-27, AGS, NCI-N87 and SNU-1) were incubated in a complete cultural medium and treated with DNA methyltransferase inhibitor, 5-Aza-20-deoxycytidine (5Aza-Dc, Sigma) and histone deacetylase inhibitor, trichostatin A (TSA, Sigma), either alone or in combination. As previously described [29 (link)], gastric cancer cells were continuously exposed to 1 μM 5Aza-Dc for 4 days or to 1 μM TSA for 24 hours. In the control group, cells were treated with PBS alone. In 5Aza-Dc+TSA group, cells were exposed to 1 μM 5Aza-Dc for 3 days and then treated with 0.5 μM TSA for additional 24 hours.
+ Open protocol
+ Expand
8

HDAC Regulation by Ins(1,4,5,6)P4

Check if the same lab product or an alternative is used in the 5 most similar protocols
For each sample, 1x106 cells were transfected with the appropriate construct and 48hr later, subjected to immunoprecipitation using the relevant antibody. For experiments measuring the effect of Ins(1,4,5,6)P4, Ins(1,4,5,6)P4 (Cayman Chemical) was added to a final concentration of 12.5μM δυρινγ ιμμuνοπρεχιπιτατιον; immunoprecipitates were collected on either Protein A or Protein G beads. HDAC assays consisted of immunoprecipitates, HDAC buffer (10 mM Tris-HCl pH 8.0, 150 mM NaCl, 1mM MgCl2), 5,000 cpm labeled histones, with or without 5μM trichostatin A (TSA; Sigma-Aldrich), in a final volume of 200μl. Samples were incubated at 37°C for 2hr on a half rotation, after which the reaction was terminated by the addition of 50μl Stop buffer (1M HCl/160mM acetic acid for labeled histones). Released 3H-acetate was extracted into 600μl ethyl acetate (Sigma-Aldrich) and the radioactivity determined using a liquid scintillation spectrometer (Beckman LS6500). Statistical analysis was performed using one-way ANOVA with post-hoc Tukey HSD.
+ Open protocol
+ Expand
9

Cell Line Maintenance and Epigenetic Modulation

Check if the same lab product or an alternative is used in the 5 most similar protocols
Twenty gastric cancer cell lines, ten colorectal cancer cell lines, and two non-gastrointestinal cancer cell lines were maintained in high-glucose DMEM with 10% fetal calf serum (Gibco/Invitrogen, Carlsbad, CA) at 37°C in a humidified 5% CO2 atmosphere. Names of used cell lines and histological types of gastric cancer cell lines were described in our previous reports [6] (link). Human T98G and A172 cell lines were purchased from the RIKEN Bio Resource Center (Tsukuba, Japan). For the treatment with DNA demethylation reagent or histone deacetylase (HDAC) inhibitor, 5-Aza-2′-deoxycytidine (5-Aza-dC, Sigma-Aldrich) at 2 µg/ml and/or trichostatin A (TSA, Sigma-Aldrich) at 25–1000 ng/ml were added to the culture medium.
+ Open protocol
+ Expand
10

Evaluating HDAC1/2 in Uremic Endothelial Dysfunction

Check if the same lab product or an alternative is used in the 5 most similar protocols
To evaluate the role of HDAC1 and HDAC2 in uraemic endothelial dysfunction, a pan‐HDAC inhibitor trichostatin A (TSA) (Sigma Aldrich) and DF were used as HDAC inhibitors. ECs on 6‐well microplates were pretreated (24 hours) with TSA (50 nmol/L) or DF (100 µg/mL) and exposed to media containing 20% of pooled sera from the uraemic patients or healthy donors, as previously described for the differential proteomic analysis. Cells were then fixed and labelled for intercellular adhesion molecule‐1 (ICAM‐1) (Millipore, Merck), Toll‐like receptor 4 (TLR4) (Abcam) and von Willebrand Factor (vWF) (DAKO) using IF, as previously described. Reactive oxygen species (ROS) production was explored by using CM‐H2DCFDA. This compound can passively diffuse into cells being oxidized by ROS to the highly fluorescent dichlorofluorescein. ROS production was monitored by fluorescence microscopy. All samples were evaluated by microscopy (Leica DM4000B), and images were captured through a videocamera (Leica DFC310FX). Fluorescence micrographs were analysed using ImageJ (version 1.43m; NIH, http://rsb.info.nih.gov/nih-image/manual/tech.html#). Cultured cells were selected from the background with the threshold tool, and the fluorescence intensity was measured.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!